Market for Deep Brain Stimulation Devices for Parkinson's Disease to be Worth USD 9.4 Billion by 2019: Transparency Market Research

Nov 19, 2015, 10:30 ET from Transparency Market Research

ALBANY, New York, November 19, 2015 /PRNewswire/ --

Transparency Market Research announces the release of a new research report titled "Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia Pacific and Rest of the World) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020". According to the report, the global market for Deep Brain Stimulation Devices for Parkinson's disease is projected to be worth USD 9.4 billion by the end of 2019.

Browse Market Research Report on Deep Brain Stimulation Devices Market:

The report provides users with an overview of the causative factors that will directly influence the demand for deep brain stimulation devices for treating persons suffering from Parkinson's disease. It speaks about various neurological disorders such as Alzheimer's disease, trauma, Parkinsonism, ischemic stroke and other similar disorders that are likely have a direct impact on the need for DBS devices. 

Get Sample Report Copy Deep Brain Stimulation Devices Market:

Parkinson's disease is characterized by symptoms such as postural instability, akinesia, and bradykinesia among others. In the recent past, incidences of Parkinson's disease have increased multifold, making it the second-most common progressive and chronic neurodegenerative disorder. The report suggests that some of the key factors that have caused an increase in the demand for DBS devices are a preference for surgical techniques that are minimally invasive-especially among the geriatric population that is more prone to this disorder. In fact, there is a growing inclination among medical practitioners as well as patients to choose DBS over drug therapy since drug therapy is known to have several side effects and its efficacy cannot be accurately gauged. The Parkinson's disease Foundation (PDF) estimates that nearly 10 million people worldwide suffer from this disorder, with one million of these living in America alone. 

Browse Press Release of Deep Brain Stimulation Devices Market:

DBS surgical therapy is the therapy of choice in the advanced stages of Parkinson's disease, whereas medical practitioners typically recommend chemotherapy in the early stages. The report discusses the aspects and considerations that make DBS devices a preferred option as compared to other treatment methods such as stem cell therapy, drug therapy, and physical therapy. 

Browse Upcoming Market Research Reports:  

This market research report by Transparency Market Research also goes on to discuss the geographical segmentation of the deep brain stimulation devices market. The market is broadly segmented as North America, Asia-Pacific, Europe and Latin America. Users can expect to gain deep insights into the market potential and growth projections for each of these markets. It also talks about factors that will promote or restrain growth in these markets.

Furthermore, the market research report offers a detailed look at the leading companies operating in the market and their profiles. 

Other Related Market Research Reports: 

  1. Global Neurology Devices Market to Reach US$13.6 billion in 2019 

The report states, the global neurology was valued US$5.0 billion in 2012 and is expected to reach US$13.6 billion in 2019, growing at a CAGR of 15.4%. The report gives a comprehensive overview about the market growth in the coming five years, the trends to watch out for, and the players who are likely to make all the difference. The neurology devices market has been segmented into interventional neurology, CSF management devices, neurostimulation devices, and neurosurgery. On the basis of geography, the global neurology devices market has been divided into North America, Europe, Asia Pacific, Latin America, and Rest of the World. Out of these segments, neurostimulation devices market segment was valued as the dominating segment and is expected to grow at a CAGR of 15% from 2013 to 2019. The interventional neurology devices market segment will also grow at a fast pace due to rising incidence of aneurysms and stroke.

Get Sample Report:

  1. Ease of Use Boosts Adoption of Lateral Flow Diagnostic Tests in APAC, Market to Reach US$3.6 bn by 2023 

The APAC lateral flow diagnostic tests market is categorized on the basis of application: pregnancy, hepatitis, HIV, influenza, syphilis, malaria, and others which includes lung disorders, cardiac markers, drug abuse, etc. The pregnancy application segment dominated the APAC lateral flow diagnostic tests market in 2014. Factors such as high sensitivity, specificity, and good stability of such tests kits is responsible for the dominance of pregnancy application segment in the APAC lateral flow diagnostic tests market. However, hepatitis application segment is expected witness the highest growth rate during the forecast period. The major factors driving the hepatitis application segment include increasing prevalence of immunological disorders in Asia Pacific coupled with easy handling of small volumes of multiple sample types

Get Sample Report:

About Us:  

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.


Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
United States.
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453



SOURCE Transparency Market Research